FDA official logo
GSRS logoPFDA official logo

DARAXONRASIB

UNII:B6T47Y2UAP
Type:INGREDIENT SUBSTANCE
Formula:C44H58N8O5S
Preferred Substance Name:DARAXONRASIB
InChIKey:
GSRS Full Record:

  • 2765081-21-6
  • (1S,2S)-N-[(12<sup>M</sup>,4S,6<sup>3</sup>S)-1<sup>1</sup>-ethyl-12-{2-[(1S)-1-methoxyethyl]-5-(4-methylpiperazin-1-yl)pyridin-3-yl}-10,10-dimethyl-5,7-dioxo-1<sup>1</sup>H-8-oxa-1(5,3)-indola-6(1,3)-[1,2]diazinana-2(4,2)-[1,3]thiazolacycloundecaphan-4-yl]-2-methylcyclopropane-1-carboxamide
  • Cyclopropanecarboxamide, N-[(2R,14S,18S)-1-ethyl-18,19,20,21-tetrahydro-2-[2-[(1S)-1-methoxyethyl]-5-(4-methyl-1-piperazinyl)-3-pyridinyl]-25,25-dimethyl-15,22-dioxo-17H-5,3-([4,2]-endo-thiazolopropano[1,3]-endo-pyridazinomethanoxypropano)-1H-indol-14-yl]-2-methyl-, (1S,2S)-
  • DARAXONRASIB [USAN]
  • Daraxonrasib
  • RMC 6236 [WHO-DD]
  • RMC-0706236
  • RMC-6236
  • daraxonrasib [INN]
  • trans-(1S,2S)-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-5-(4-methylpiperazin-1-yl)-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methylcyclopropane-1-carboxamide



UNII - B6T47Y2UAP | UNII Search Service